PD-1 Blockade by CT-011, Anti-PD-1 Antibody, Enhances Ex Vivo T-cell Responses to Autologous Dendritic Cell/Myeloma Fusion VaccineJacalyn Rosenblatt, David Avigan, Brett Glotzbecker et al.|Journal of Immunotherapy|2011Cited by 285
Vaccination with Dendritic Cell/Tumor Fusions following Autologous Stem Cell Transplant Induces Immunologic and Clinical Responses in Multiple Myeloma PatientsJacalyn Rosenblatt, David Avigan, Irit Avivi et al.|Clinical Cancer Research|2013Cited by 209
Lenalidomide enhances anti-myeloma cellular immunityKatarina Luptakova, David Avigan, Jacalyn Rosenblatt et al.|Cancer Immunology Immunotherapy|2012Cited by 161
MUC1 Is a Potential Target for the Treatment of Acute Myeloid Leukemia Stem CellsDina Stroopinsky, David Avigan, Jacalyn Rosenblatt et al.|Cancer Research|2013Cited by 54
Immunomodulatory effects of vitamin D: implications for GVHDJacalyn Rosenblatt, David Avigan, Adam Bissonnette et al.|Bone Marrow Transplantation|2010Cited by 43